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Background: Mild solubilization of inclusion bodies has attracted attention in recent days, with an objective to
preserve the existing native-like secondary structure of proteins, reduce protein aggregation during refolding and
recovering high amount of bioactive proteins from inclusion bodies.
Results: Here we presented an efficient method for mild solubilization of inclusion bodies by using a freeze-
thawing process in the presence of low concentration of urea. We used two different proteins to demonstrate the
advantage of this method over the traditional urea-denatured method: enhanced green fluorescent protein (EGFP)
and the catalytic domain of human macrophage metalloelastase (MMP-12_CAT). Firstly, PBS buffer at pH 8 containing
different molar concentration of urea (0-8 M) were used to solubilize EGFP and MMP-12-CAT inclusion bodies and
the solubility achieved in 2 M urea in PBS buffer by freeze-thawing method was comparable to that of PBS buffer
containing 8 M urea by traditional urea-denatured method. Secondly, different solvents were used to solubilize
EGFP and MMP-12_CAT from inclusion bodies and the results indicated that a wide range of buffers containing
2 M urea could efficiently solubilize EGFP and MMP-12_CAT inclusion bodies by freeze-thawing method. Thirdly,
the effect of pH and freezing temperature on the solubility of EGFP and MMP-12_CAT inclusion bodies were studied,
revealing that solubilization of inclusion bodies by freeze-thawing method is pH dependent and the optimal
freezing temperature indicated here is −20°C. Forth, the solubilized EGFP and MMP-12_CAT from inclusion bodies
were refolded by rapid dilution and dialysis, respectively. The results showed that the refolded efficiency is much
higher (more than twice) from freeze-thawing method than the traditional urea-denatured method. The freeze-thawing
method containing 2 M urea also effectively solubilized a number of proteins as inclusion bodies in E.coli.
Conclusions: Mild solubilization of inclusion body proteins using the freeze-thawing method is simple, highly
efficient and generally applicable. The method can be utilized to prepare large quantities of bioactive soluble
proteins from inclusion bodies for basic research and industrial purpose.
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E.coli have been most widely used for the production of
recombinant proteins in large amounts, due to notice-
able advantages such as easy of manipulation, growth
on inexpensive carbon sources and fast in generation of
a recombinant protein [1,2]. However, heterologous
protein over-expression in E.coli often leads to the
target protein accumulating in dense water-insoluble* Correspondence: sdxiongfd@126.com
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unless otherwise stated.aggregates, known as inclusion bodies, only about 30% of
them were expressed in soluble forms [3]. In general, to
obtain soluble active proteins from inclusion bodies, the
inclusion bodies are solubilized by the use of high concen-
tration of denaturing reagents such as urea or guanidi-
nium chloride, and then followed by a step of refolding
process using various refolding techniques involving slow
removal of the denaturant agents [4-7]. The use of the
strong denaturants results in the loss of secondary struc-
ture leading to the random coil and exposure of the
hydrophobic surface, which is considered to be the main
reason for the poor recovery of bioactive protein from theis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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bioactive protein from inclusion bodies is around 15–25%
of the total protein and amount of precipitation is formed
during the refolding process [8]. Also, renaturation of
most proteins is performed at rather low protein concen-
trations (10–100 μg/mL), which is not very convenient on
the industrial scale [10]. Despite extensive experimental
and theoretical work has been made to produce soluble
proteins from inclusion bodies, refolding of the denatured
proteins remains a major bottleneck in supplying recom-
binant proteins for research and industrial applications
[5,11-14]. It has been widely documented that inclusion
bodies are pure, structurally organized, mechanically
stable and biocompatible protein deposits and have
native-like secondary structure [15-19]. Mild solubilization
of inclusion body aggregates has attracted attention in re-
cent days, it allows for preservation of existing native-like
secondary structure of proteins, reduces protein aggre-
gation during refolding and allows for recovery of high
amount of bioactive proteins from inclusion bodies
[20,21]. In recent years, many novel solubilization
methods without using high concentration of denatur-
ing reagents have been developed for solubilization and
recovery of bioactive protein form inclusion bodies
[13,14,22-24].
Proteins are routinely stored as frozen solutions with
the aim of long-term stability. It has been reported that
freezing and thawing of protein solutions can cause
protein denaturation and destabilize the tertiary struc-
ture of proteins with retention of secondary structure
[25-27]. There are no reports on solubilization and sub-
sequent refolding of inclusion body proteins using
freeze-thawing process. In this study, we explored the
possibilities of solubilizing inclusion bodies expressed in
E.coli with freeze-thawing process in presence of low
concentration of urea, which was referred to as freeze-
thawing method. In this procedure, the inclusion bodies
are suspended in PBS buffer containing 2 M urea,
followed by freezing at −20°C and thawing at room
temperature, and centrifuged to collect the supernatant.
Such an inclusion body protein solubilization strategy is
depicted in Figure 1 and has been successfully applied
for solubilizing several recombinant proteins expressed
as inclusion bodies in E.coli, thus providing a novel
method for solubilization of a large range of inclusion
body proteins in the presence of low concentration of
denaturants. Such mild denaturing conditions facilitate
the subsequent refolding and purification procedure
resulting in high recovery of bioactive protein.
Results
Reason for choice of two representative proteins
To test solubilization capacity and refolding efficiency by
the freeze-thawing method and to compare with thetraditional urea-denatured method, we analyzed two
proteins, EGFP and MMP-12_CAT. EGFP (27 kDa)
could be produced in both active form and inactive in-
clusion bodies in E. coli expression system depending on
inducing protein over-expression conditions [28,29].
Meanwhile, the green fluorescence of EGFP can be easily
measured by fluorescence spectrometry and can be used
as a sensitive assay to monitor protein folding [28]. Hu-
man macrophage metalloelastase (MMP-12) belongs to
the family of zinc endoproteases that have the ability to
degrade all of the major protein constituents of the
extracellular matrix. MMP-12 is secreted from cells as a
54-kDa proenzyme or zymogen [30]. Upon activation,
MMP-12 cleaves both its N-terminal prodomain and its
C-terminal hemopexin-like domain, resulting in a mature,
active, 22 kDa catalytic domain [30,31]. Previous study
have shown that the catalytic domain of human macro-
phage metalloelastase (MMP-12_CAT) are expressed at
high levels in E. coli only as inclusion bodies, and its active
form could be obtained by using high concentration of de-
naturing reagents denaturing and refolding [3,31]. Also,
the activity of MMP-12_CAT was able to determine by
using the fluorometric substrate Mca-PLGLEEA-Dpa-
NH2 which is commercial available [32]. So, we can
compare the solubilization capacity and refolding effi-
ciency of MMP-12_CAT from freeze-thawing method
with that from traditional urea-denatured method.Isolation of EGFP and MMP-12_CAT inclusion bodies
The EGFP and MMP-12_CAT proteins were efficiently
expressed using their expression vector in E.coli. As pre-
viously reported, EGFP could be produced in both
soluble form and insoluble inclusion bodies strongly de-
pends on the growth temperature [3,28], with growth at
a low temperature of 16°C resulting into the highest per-
centage of correctly folded protein (data not shown); at
high growth temperature (37°C), EGFP was found to be
mainly as insoluble inclusion bodies (Figure 2). In the
case of MMP-12_CAT, all of the protein was only found
in the insoluble pellet after cell-lysis and not in the sol-
uble fraction (Figure 2). After centrifugation of the cell-
lysate and removal of the supernantant, the pelleted
crude inclusion bodies were mainly contaminated by the
cell envelope and the membrane cellular debris. Exten-
sive washing with detergents containing buffer such as
Triton X-100 and/or low concentrations of chaotropic
compounds helped in removing the majority of the con-
taminants and resulted in pure inclusion bodies. At this
stage, inclusion bodies purity is more than 90% and
therefore less downstream steps are necessary to purify
the protein (Lane T, Figure 3). The purified inclusion
bodies containing mostly EGFP and MMP-12_CAT were
used for subsequent solubilization and refolding.
Pure inclusion bodies
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Figure 1 Scheme for the efficient production of soluble protein from bacterial inclusion bodies using freeze-thawing method.
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Comparative solubilization of inclusion bodies by two
different methods
The solubilization power of freeze-thawing method was
compared with that of urea-denatured method. Purified
inclusion bodies of EGFP and MMP-12_CAT (10 mg/
ml wet weight for final concentration) were solubilized
in PBS buffer at pH 8 containing different molar con-
centration of urea. SDS–PAGE analysis of the solubi-
lized supernatants of these inclusion bodies and proteinconcentration was measured by Micro BCA Protein
Assay Kit (Thermo), BSA as standard protein (Figure 3
and Table 1). It was observed that EGFP and MMP-
12_CAT inclusion bodies could be solubilized in PBS
buffer containing 5–8 M urea by traditional urea-
denatured method, while PBS buffer containing lower
concentration of urea (0–3 M) did not solubilize EGFP
and MMP-12_CAT inclusion bodies (Figure 3A and C).
There was slight solubilization of EGFP and MMP-
12_CAT from inclusion bodies in presence of 4 M urea
(Lane 4, Figure 3A and C). For freeze-thawing method,
Figure 2 SDS-PAGE analysis of EGFP and MMP-12_CAT over-
expression in E.coli as inclusion bodies. E. coli BL21 (DE3) cells
harbouring expression vector of EGFP and MMP-12 catalytic domain,
respectively, were induced with IPTG at 37°C for 4 hours. Equivalent
numbers of uninduced (U1 and U2) and induced cells (I1 and I2) are
shown. Equivalent proportions of the soluble fractions (S1 and S2)
and insoluble inclusion bodies (P1 and P2) are shown. The number 1
represents E.coli cells harbouring MMP-12_CAT expression vector and
number 2 represents E.coli cells harbouring EGFP expression vector.
MMP-12_CAT runs as the band of 22 kDa and EGFP as the band of
27 kDa in accordance with their expected size. Molecular weight
markers (M) are shown and their sizes in kilodaltons are indicated
on the left.
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solubilize EGFP and MMP-12_CAT inclusion bodies
(Figure 3B and D). Maximum solubilization of EGFP
and MMP-12_CAT from inclusion bodies was achieved
in PBS buffer containing 2 M urea by freeze-thawingFigure 3 SDS-PAGE analysis of EGFP and MMP-12_CAT
solubilization from inclusion bodies in PBS buffer containing
different molar concentration of urea by two different methods.
The same amount of EGFP and MMP-12_CAT inclusion bodies
was suspended in PBS buffer at pH 8 containing different molar
concentration of urea (0-8 M) and solubilized by freeze-thawing
method and traditional urea-denatured method. SDS-PAGE analysis
of the solubilization of EGFP from inclusion bodies in different
molar concentration of urea by traditional urea-denatured method
(A) and freeze-thawing method (B); SDS-PAGE analysis of the
solubilization of MMP-12_CAT from inclusion bodies in different
molar concentration of urea by traditional urea-denatured method
(C) and freeze-thawing method (D). T stands for cleaned total
inclusion bodies.method and higher concentration of urea almost did
not further solubilize GFP and MMP-12_CAT from in-
clusion bodies. It was also observed that PBS buffer
alone did not solubilize inclusion body proteins (Lane 0,
Figure 3B and D). The results indicated that the solubility
achieved in 2 M urea in PBS buffer by freeze-thawing
method was comparable to that of PBS buffer containing
8 M urea by traditional urea-denatured method.
Solubilization of inclusion bodies in different solvents
The solubilizing effect of PBS buffer at pH 8 containing
2 M urea on EGFP and MMP-12_CAT inclusion bodies
was compared with different solubilizing buffers as de-
scribed under Materials and Methods. It was observed
that the solubility achieved in 20 mM NaP, 20 mM KP,
20 mM Tris–HCl, and deionized water containing 2 M
urea was comparable to that of PBS buffer containing
2 M urea by freeze-thawing method (Figure 4). The re-
sults indicated that a wide range of buffers containing
2 M urea by freeze-thawing method could efficiently
solubilize EGFP and MMP-12_CAT proteins from inclu-
sion bodies and the solubilize efficiency was comparable
to that of traditional urea-denatured method.
Solubilization of inclusion bodies at different pH
The low concentration of potassium phosphate buffer
with minmizing pH change during the freezing process
was chosen for study the effect of pH on the solubility of
inclusion bodies [25,27]. The purified EGFP and MMP-
12_CAT inclusion bodies were solubilized at different
pHs (pH 5–10) in 20 mM potassium phosphate buffer
containing 2 M urea and percentage solubilization was
monitored (Figure 5). Solubilization of EGFP and MMP-
12_CAT from inclusion bodies was observed by increasing
the pH from 5 to 10. SDS–PAGE showed that EGFP in-
clusion bodies could be solubilized in potassium phos-
phate buffer at pH 7–10 containing 2 M urea and very
low amount of EGFP inclusion bodies could be solubilized
at low pH (pH 5 and 6). In the case of MMP-12_CAT, po-
tassium phosphate buffer at pH 5–7 containing 2 M urea
did not solubilize protein from inclusion bodies. In con-
trast, potassium phosphate at high pH (pH 8–10) contain-
ing 2 M urea solubilized maximum amount of protein
form the inclusion bodies of MMP-12_CAT. The results
indicated that inclusion body solubilization by freeze-
thawing method in the presence of low concentration of
urea is pH dependent and optimum pH conditions must
be determined for each protein.
Effect of freezing temperature
The solubilizing effect of freezing temperature on EGFP
and MMP-12_CAT inclusion bodies was performed in
20 mM potassium phosphate buffer at pH 8 containing
2 M urea. As shown in Figure 6, EGFP inclusion bodies
Table 1 Comparative the solubilized protein of EGFP and MMP-12_CAT from inclusion bodies in different concentration





Urea-denatured Freeze-thawing Urea-denatured Freeze-thawing
PBS, pH 8, 0 M urea 115 241 58 202
PBS, pH 8, 1 M urea 116 987 101 1399
PBS, pH 8, 2 M urea 164 1167 109 1594
PBS, pH 8, 3 M urea 252 1274 145 1623
PBS, pH 8, 4 M urea 432 1314 505 1601
PBS, pH 8, 5 M urea 1335 1289 1837 1580
PBS, pH 8, 6 M urea 1371 1331 1819 1292
PBS, pH 8, 7 M urea 1262 1187 1755 1861
PBS, pH 8, 8 M urea 1246 1181 1681 1523
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pH 8 containing 2 M urea at freezing temperature −20°C,
−40°C and −80°C, which indicated that the freezing
temperature has little effect on the solubilization effi-
ciency of EGFP inclusion bodies. In contrast, potassium
phosphate buffer containing 2 M urea solubilized very
low amount of MMP-12_CAT inclusion bodies while
freezing at −40°C and −80°C (Figure 6). The results in-
dicated that the effect of freezing temperature on the
solubility of inclusion bodies depends on the protein
and the optimal freezing temperature indicated here
is −20°C.
Comparative refolding yield of EGFP and MMP-12_CAT
from two different methods
In the case of EGFP, fluorescence was taken as a sign of
a correctly folded and oxidized protein. During theFigure 4 Effect of different solvents on the solubility of EGFP and MMP
inclusion bodies was suspended in different solvents containing 2 M urea and
of different solvents on the solubility of EGFP inclusion bodies. (B) SDS-PAGE
inclusion bodies. PBS, PBS at pH 8 with 2 M urea; NaP, 20 mM sodium phosph
2 M urea; Tris, 20 mM Tris at pH 8 with 2 M urea; H2O, deionized water at pH
analysis using ImageJ Software.repaid dilution step, there was no precipitation observed.
The fluorescence spectrum of EGFP refolded from in-
clusion bodies was compared to the EGFP soluble ex-
pression at the concentration of 0.5 mg/ml. As shown
in Figure 7A, the maximal fluorescent intensities at
510 nm were 72023 RFU for the soluble expressed
EGFP, 38468RFU for the refolded EGFP from the
freeze-thawing method with 2 M urea and 18074RFU
for refolded EGFP from the traditional urea-denatured
method with 8 M urea. Therefore, when comparing the
fluorescence emission at 510 nm of refolded EGFP to
that of EGFP from soluble expressed, it showed that the
solubilizd EGFP protein from freeze-thawing method had
53.4% recovery ratio comparing to 25.1% from the trad-
itional urea-denatured method.
In contrast to the direct dilution method, solubilized
MMP-12_CAT was refolded by the utilization of dialysis-12_CAT inclusion bodies. A fixed amount of EGFP and MMP-12_CAT
solubilized by freeze-thawing method. (A) SDS-PAGE analysis of effect
analysis of effect of different solvents on the solubility of MMP-12_CAT
ate at pH 8 with 2 M urea; KP, 20 mM potassium phosphate at pH 8 with
8.5 with 2 M urea. (C) Protein bands were quantitated by densitometric
Figure 5 Effect of pH on the solubility of EGFP and MMP-12_CAT inclusion bodies by freeze-thawing method. A constant amount of
EGFP and MMP-12_CAT inclusion bodies was solubilized at different pH in 20 mM potassium phosphate buffer containing 2 M urea by freeze-
thawing method. (A) SDS-PAGE analysis of effect of pH on the solubility of EGFP inclusion bodies. (B) SDS-PAGE analysis of effect of pH on the
solubility of MMP-12_CAT inclusion bodies. (C) Protein bands were quantitated by densitometric analysis using ImageJ Software.
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allowed the change from denaturing to native buffer
conditions occurs gradually. After dilution to the
refolding buffer without urea, appreciable precipitation
was observed. After centrifugation, the supernatant
containing refolded MMP-12_CAT was collected and
performed the activity assay. The biochemical activity
of the refolded MMP-12_CAT from freeze-thawing
method was measured as △RFU/△T at 25°C is 3970.6
RFU, comparable with 1555.8 RFU of the refolded
MMP-12_CAT from traditional urea-denatured method
(Figure 7B).
In summary, the comparison studies of EGFP and
MMP-12_CAT demonstrated that the refolding yield
with the freeze-thawing method is significantly better
(more than twice) than the traditional urea-denatured
method.Figure 6 Effect of freezing temperature on the solubility of EGFP an
The same weight of EGFP and MMP-12_CAT inclusion bodies was solubilized
freezing at different temperatures by freeze-thawing method. (A) SDS-PA
inclusion bodies. (B) SDS-PAGE analysis of effect of freezing temperature
were quantitated by densitometric analysis using ImageJ Software.Existence of native-like secondary structure of EGFP by
freeze-thawing method
To validate the mild solubilization strategy of inclusion
body protein by freeze-thawing method, the native like
secondary structure of solubilized EGFP was monitored
by CD and fluorescence spectroscopy (Figure 8). As
shown in Figure 8A, fluorescence of two solubilized
EGFP samples by two different methods was recorded.
The maximal fluorescent intensities at 510 nm were
4401RFU with 2 M urea from the freeze-thawing
method (2 M urea), suggesting that EGFP proteins were
solubilized as both active and inactive forms by freeze-
thawing method. The fluorescence intensity of dena-
tured EGFP from traditional urea-denatured method
(8 M urea) was almost overlapped into a horizontal
line, which indicated that the solubilized EGFP from in-
clusion bodies was as inactive form. This was furtherd MMP-12_CAT inclusion bodies by freeze-thawing method.
in 20 mM potassium phosphate buffer at pH 8 containing 2 M urea and
GE analysis of effect of freezing temperature on the solubility of EGFP
on the solubility of MMP-12_CAT inclusion bodies. (C) Protein bands
Figure 7 Activity assay of refolded EGFP and MMP-12_CAT from inclusion bodies. (A) Fluorescence spectra of refolded EGFP by freeze-
thawing method (Refold EGFP from 2 M urea) and traditional urea-denatured method (Refold EGFP from 8 M urea) compared to native EGFP
(Solubly expressed EGFP). (B) Fluorescence increase for the degradation of the Mca-PLGLEEA-Dpa-NH2 (8 uM) by refolded MMP-12_CAT (5 nM) at
25°C from freeze-thawing method and traditional urea-denatured method.
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freeze-thawing method (Figure 8B). It was observed
that EGFP in presence of 2 M urea has native-like sec-
ondary structure as observed with the native EGFP.
General applicability of the freeze-thawing method
To further investigate the universal applicability of the
freeze-thawing method, inclusion bodies of five more re-
combinant proteins (over-expressed in E.coli only as in-
clusion bodies) with different molecular weight and
protein physicochemical properties were prepared using
the same protocol as EGFP and MMP-12_CAT inclusion
bodies. The five inclusion body proteins were named as
RBW4SG (95 kDa), GFP-RecA (55 kDa), Trx-VP1
(56 kDa), CRT/1-180 (20 kDa) and C-VP1 (34 kDa).
C-VP1 is a circular protein produced by covalent
cyclization of its backbone by protein trans-splicing,
while the others are linear protein forms. Inclusion bod-
ies were suspended in PBS buffer at pH 8 containing
2 M urea and frozen at −20°C overnight, then thawed atFigure 8 Fluorescence and CD spectra of solubilized EGFP from inclu
freeze-thawing method (2 M urea) and traditional urea-denatured metho
thawing method.room temperature. Centrifuged and collected the super-
natants to analyze by SDS-PAGE to check the solubility
of these inclusion bodies (Figure 9). It was observed that
all the five inclusion bodies could be solubilized using
the freeze-thawing method in presence of 2 M urea and
the overall yield of soluble proteins was nearly 100%.
This indicated that the freeze-thawing method could be
used for solubilization of a wide range of recombinant
proteins expressed as inclusion bodies in E.coli.
Discussion
Recently study showed that proteins inside inclusion
body aggregates have native-like secondary structures
[15,16]. It is assumed that retaining of this native-like
secondary structure using mild solubilization conditions
will help in improved recovery of bioactive protein in
comparison to solubilization using a high concentration
of chaotropic agent [20,22,24]. In order to develop an
efficient and economic mild solubilization conditions to
solubilize inclusion bodies and to get higher finalsion bodies. (A) Fluorescence spectra of solubilized EGFP from
d (8 M urea). (B) Far UV CD spectra of solubilized EGFP by freeze-
Figure 9 SDS–PAGE analysis of five solubilized proteins from
inclusion bodies. Five inclusion body proteins were suspended in
PBS buffer (pH 8) containing 2 M urea and followed by freezing
at −20°C and thawing at room temperature. Lane M is marker (170,
130, 100, 70, 55, 40, 35, 25, 15 kDa), T stands for cleaned total
inclusion bodies, S stands for solubilized protein supernatants from
inclusion bodies.
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solubilization agents have been tried. Extreme pH (≤2.6
or ≥ 12) [21,22], has been used to solubilize inclusion
bodies. Although the extreme pH solubilization method
is attractive for its simplicity and low cost, it may cause
irreversible chemical modifications to the protein and
not be applicable to most pharmaceutical proteins [5].
Detergents such as sodium dodecyl sulfate (SDS) and n-
cetyl trimethylammonium bromide (CTAB) were also
been used to solubilize inclusion bodies [28,33,34], how-
ever, the use of detergents as solubilizing agents may
interfere with downstream chromatographic steps and
extensive washing process may be needed to remove
solubilizing detergents. In this report, we described a
novel way of mild solubilization of inclusion bodies by
using low concentration of urea combined with a freeze-
thawing process. Inclusion bodies of EGFP and MMP-
12_CAT were isolated to more than 90% purity by
extensive washing. As the inclusion bodies consisted of
almost target protein only, solubilization and refolding
were carried out without further purification. The effi-
ciency of solubilization inclusion bodies in several sol-
vents containing 2 M urea by freeze-thawing method
(freezing at −20°C and thawing at room temperature)
was found to be comparable with that of 8 M urea. This
suggested that a wide range of solvents could efficiently
solubilize inclusion bodies by freeze-thawing method
and appropriate buffer can be chosen to solubilize in-
clusion bodies according to the downstream applications.
Our results also showed that the yield of bioactive EGFP
and MMP-12_CAT from inclusion bodies were signifi-
cantly better than the traditional urea-denatured method.
The freeze-thawing method combined 2 M urea also solu-
bilized many inclusion body proteins expressed in E. coli
only as inclusion bodies indicating that the method has
the capacity to solubilize different types of inclusion body
aggregates.Since potassium phosphate buffer with a low concen-
tration does not change its pH significantly (<1 Unit)
during freezing, so 20 mM potassium phosphate
was chosen to study the effect of pH and freezing
temperature on the solubility of EGFP and MMP-
12_CAT inclusion bodies [25,27,35]. 20 mM potassium
phosphate at alkaline pH (8–10) in the presence of low
concentration of urea (1–2 M) was responsible for
higher solubilization of EGFP and MMP-12_CAT inclu-
sion bodies. Low concentration of urea and alkaline pH
are both essential factors for highly solubilization of in-
clusion bodies by freeze-thawing method. Increased
solubility of EGFP and MMP-12_CAT could be an effect
of both urea and pH, indicating the existence both ionic
and hydrophobic interactions in the inclusion bodies
[22]. Since proteins could not be denatured at such
a low concentration of urea and at a mild alkaline pH
(8–10), urea was probably only serving the purpose of
physical separation of the molecules by disrupting the
hydrophobic interactions of protein molecules [36,37].
The alkaline pH distant from the isoelectric point of the
protein of buffer has a crucial role in destabilizing the
inclusion body aggregation, thus rendering them sol-
uble in the presence of very low concentrations of
denaturants.
The mechanism of freezing and thawing on protein
stability has been extensively studied [25-27,35,38,39].
Previous study show that freezing can induce several
stresses during the freezing process that are capable of
denaturing proteins, such as cold temperature, ice crys-
tals formed, the buffer salts concentration, and resultant
pH changes. Since 20 mM potassium phosphate buffer
has little change in its pH during freezing, hence pH
-induced solubilization of inclusion bodies is excluded
during freezing process. Meanwhile, deionized water just
containing 2 M urea could efficiently solubilize EGFP
and MMP-12_CAT inclusion bodies, which also exclude
the salt concentration-induced solubilization of inclusion
bodies. So, the main force of solubilization of inclusion
bodies by freeze-thawing method should mainly indicate
towards the stress of cold temperature and ice crystals
formed during freezing process. Our study also showed
that the freezing temperature had big effect on the solu-
bility of MMP-12_CAT inclusion bodies.
Multimeric proteins have been observed to undergo
freezing-induced dissociation but maintain their native
secondary structure [25,35,40-42]. Inclusion bodies are
composed of aggregates of partially folded protein inter-
mediates and the proteins inside inclusion body aggre-
gates have extensive native-like secondary structure.
Inclusion bodies can be seen as large multimeric pro-
teins composed of numbers of monomers, the large mul-
timeric protein are prone to dissociation to subunits
during freezing and thawing process, and the dissociated
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maintain soluble form in the presence of low concentra-
tion of urea and at alkaline pH. Once the inclusion body
proteins are solubilized under such mild conditions, the
subsequent refolding and purification are easier resulting
in high recovery of the bioactive protein. Several groups
have also reported that properly folded protein might be
trapped inside inclusion bodies [29,43-45]. This protein
can be released from inclusion bodies with mild deter-
gents under non-denaturing conditions. In our freeze-
thawing method, the active EGFP protein was also
obtained from such inclusion bodies without any rena-
turation procedure. However, in current study we did
not investigated the effect of different solvents on the
secondary structure of solubilized proteins and the yields
of recovering bioactive protein form inclusion bodies.
Also, the effect of cooling and warming rate on protein
secondary structure and recovery efficiency during the
freezing and thawing process were needed to be study.
Further studies to optimize the conditions for maximizing
refolding proteins from inclusion bodies are necessary.
Conclusion
In summary, the freeze-thawing method is much more
convenient, simply, time-saving and efficient compared
to the traditional urea-denatured method. Solubilization
of inclusion body proteins at such a mild condition pre-
serves the native-like secondary structure of the solubi-
lized proteins and facilitates improved recovery of the
bioactive protein. The freeze-thawing method also has
the capacity to solubilize a board range of inclusion body
proteins. With such multiple advantages, freeze-thawing
method might be a viable alternative to high concentra-
tion of denaturing agents based solubilization of inclu-
sion body protein. As the yield of recovery of bioactive
protein is high using freeze-thawing method, such tech-
nique can be applied for maximizing the recovery of
proteins from inclusion bodies expressed in E.coli, espe-
cially for large scale for industrial processes.
Materials and methods
Expression of EGFP as soluble form and insoluble
inclusion bodies in E.coli
The gene encoding enhanced GFP was cloned from
pEGFP-N1 plasmid (BD Clontech, Palo Alto, CA) and
inserted into pET28a expression vector and transferred
into BL21 (DE3). When the cells were grown in LB
medium at 37°C with the absorbance at 600 nm (OD
600) reached 0.8, a final concentration of 1 mM IPTG
was added to induce the EGFP soluble expression at
16°C for another 16 hours, otherwise insoluble form was
induced at 37°C for 4 hours. For EGFP soluble expres-
sion, the cells were harvested at 5,000 g at 4°C for 20 mi-
nutes and resuspended in 30 ml of PBS buffer (137 mMNaCl, 2.7 mM KCl, 10 mM Na2HPO4 · 12H2O, 2 mM
KH2PO4, pH 8.0), and then lysed by sonication on ice
(Branson Sonifier 450, USA). The lysate was centrifuged
at 12,000 g at 4°C for 20 minutes. The clarified super-
natant was collected and purified by Ni-NTA affinity
chromatography (GE healthcare) following the instruc-
tions. For insoluble expression, cells were harvested at
5,000 g at 4°C for 20 minutes and the pellets were stored
at −20°C.
Expression of catalytic domain of MMP-12 in E.coli
The gene coding for the catalytic domain of human
MMP-12 (Gly106 to Asn268) was cloned into BamHI
and NdeI sites of a T7-based expression plasmid pET11c
vector (Novagen) [3,31]. The 163-residue catalytic do-
main of MMP-12 (MMP-12_CAT) was expressed in E.
coli BL21 (DE3) cells transformed with the expression
plasmid. Cells were cultured at 37°C in LB medium sup-
plemented with 100 ug/ml of ampicillin. Protein expres-
sion was induced when the cells had grown to an OD
600 value of 0.8 by the addition of IPTG to a final con-
centration of 1 mM. Cells were harvested 4 hours
post-induction by centrifugation at 5,000 g at 4°C for
20 minutes, and the pellets were stored at −20°C.
Isolation of pure EGFP and MMP-12_CAT inclusion bodies
from E. coli cells
Cell pellets were thawed briefly at room temperature
and resuspended in 30 ml of PBS buffer. The mixture
was sonicated on ice until a homogeneous suspension
was formed. The resulting cell lysate was centrifuged at
12,000 g for 20 minutes. The supernatant (S) was
retained for analysis by SDS–PAGE, the insoluble inclu-
sion bodies (P) were resuspended in 30 ml of washing
buffer (20 mM Tris, 300 mM NaCl, 1 mM EDTA, 1%
Triton X-100, 1 M urea, pH 8.0) and also analyzed by
SDS–PAGE. In order to obtain pure EGFP and MMP-
12_CAT inclusion bodies, the pellets were washed ex-
tensively for three times with 30 ml of washing buffer.
Finally, the inclusion bodies were washed with PBS buf-
fer to remove contaminating detergent and centrifuged
at 12,000 g for 20 minutes and the purified inclusion
bodies were used for subsequent solubilization and
refolding.
Comparative solubilization of EGFP and MMP-12_CAT
inclusion bodies by two different methods
In order to compare the solubilization power of freeze-
thawing method with that of urea-denatured method,
the same amount of purified EGFP and MMP-12_CAT
inclusion body pellets was resuspended in PBS buffer at
pH 8 containing different molar concentration of urea
(0-8 M). For the traditional urea-denatured method,
the suspension was stirred for 30 minutes at room
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to collect the supernatant. For the freeze-thawing
method, the suspension was frozen at −20°C and thawed
at room temperature, centrifuged at 12,000 g for 15 mi-
nutes at 4°C to collect the supernatant. Supernatants
(10ul) were analyzed by SDS–PAGE to check the quality
of the protein. Protein concentration was estimated by
Micro BCA Protein Assay Kit (Thermo) and BSA was
used as standard for the estimation of protein concentra-
tion (Table 1).
Solubility of EGFP and MMP-12_CAT inclusion bodies in
different solvents
Five different solvents in presence of 2 M urea were
employed to solubilize EGFP and MMP-12_CAT inclu-
sion bodies: PBS (pH 8), 20 mM sodium phosphate
(NaP, pH 8), 20 mM potassium phosphate (KP, pH 8),
20 mM Tris–HCl (pH 8), and deionized water (pH 8.5).
Homogenous inclusion body suspension in PBS buffer
was centrifuged and the same volume of each of the
above solubilizing solvents was added to the pellets. Sus-
pension was frozen at −20°C for overnight and thawed
at room temperature, and was centrifuged at 12,000 g
for 15 minutes at 4°C to get clear supernatant. Superna-
tants (5ul) were analyzed by SDS–PAGE to check the
quality of the protein. Protein bands were quantitated by
densitometric analysis using ImageJ Software (National
Institutes of Health, Bethesda, MD).
Solubility of EGFP and MMP-12_CAT inclusion bodies in
potassium phosphate buffer at different pH
Purified EGFP and MMP-12_CAT inclusion bodies
were solubilized in 20 mM potassium phosphate buffer
at different pHs (5–10) in the presence of 2 M urea.
Homogenous inclusion body suspension in potassium
phosphate buffer at different pHs was frozen at −20°C and
thawed at room temperature, centrifuged at 12,000 g for
15 minutes at 4°C to get clear supernatant. Supernatants
(5ul) were analyzed by SDS–PAGE. Protein bands were
quantitated by densitometric analysis using ImageJ
Software.
Optimization of freeze temperature for solubilization of
EGFP and MMP-12_CAT inclusion bodies
Homogenous suspension of EGFP and MMP-12_CAT
inclusion bodies was solubilized in 20 mM potassium
phosphate buffer at pH 8 containing 2 M urea. The sus-
pension was frozen at −20°C, −40°C and −80°C for
overnight, respectively. Then, the suspension was thawed
at room temperature and centrifuged (12,000 g, 4°C,
15 minutes) to collect the supernatant. Supernatants (5ul)
were also analyzed by SDS–PAGE. Protein bands were
quantitated by densitometric analysis using ImageJ
Software.Recovery of bioactive EGFP and MMP-12_CAT from
inclusion bodies
The solubilized EGFP from inclusion bodies in PBS buf-
fer at pH 8 containing 2 M urea from freeze-thawing
method and 8 M urea from traditional urea-denatured
method were refolded by rapid dilution. This was done
by adding solubilized proteins drop wise into PBS buffer
at pH 8 until a final urea concentration of 1 M and
stored at 4°C for one week.
Fractions containing solubilized MMP-12_CAT from
inclusion bodies in PBS buffer at pH 8 containing 2 M
urea (from freeze-thawing method) and 8 M urea (from
traditional urea-denatured method) were used to obtain
active forms. To avoid precipitation shown up, the con-
centration of MMP-12_CAT was adjusted to 0.5 mg/ml,
and then placed into a MWCO 5 kDa dialysis mem-
brane, and then diluted into refolding buffer (20 mM
Tris, 100 mM NaCl, 10 mM CaCl2, 0.2 Mm ZnCl2,
pH 7.5). Each dialysis step was performed at 4°C for
12 hours against ten volumes of the dialysis buffer and
three buffer changes in each step.
Fluorescence and Circular Dichroism spectra of EGFP
samples
Fluorescence emission spectra of EGFP were recorded
using a Synergy H4 Hybrid Microplate Reader (Biotek).
The fluorescence spectra of five EGFP samples at
0.5 mg/ml concentrations were measured, including sol-
uble expressed EGFP, two unfolded EGFP and two
refolded EGFP. EGFP samples were excited at 450 nm
and emission spectra were collected from 480–570 nm.
To investigate the secondary structure contents of
EGFP samples obtained from freeze-thawing method,
CD spectra of solublilized EGFP (5 μM of protein con-
centration in 20 mM Tris–HCl with 2 M urea) were re-
corded using J-815 spectro-polarimeter (Jasco) in the
wavelength range of 190–250 nm at 25°C. The photo-
multiplier voltage read never exceeded 600 V in the
spectral regions. Each spectrum was scanned five times
and the average spectrum was plotted. The cuvette path
length was 1 mm for far-UV region measurements with
a step size of 0.5 nm and a bandwidth of 1 nm.
Fluorescent enzymatic assay of refolded MMP-12_CAT
The activity of two refolded MMP-12_CAT samples
was determined using the fluorometric substrate Mca-
PLGLEEA-Dpa-NH2 (ANASPEC) (27). Reactions (200
ul) were performed at 25°C, using a substrate concentra-
tion of 8 um and 5 nm MMP-12_CAT in assay buffer
(50 mM Tris–HCl, 10 mM CaCl2, 0.05% Brij-35 (v/v),
pH 7.4) in black 96-well plates (Corning). The release of
the fluorescent product McaPL was monitored continu-
ously using a Synergy H4 Hybrid Microplate Reader
(Biotek). The excitation filter used was 325 nm with a
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with a bandwidth of 20 nm. The selected gain was 4
with readings every 1 minute for 14 cycles, where the
cleavage of substrate was linear with respect to time.
Expression of five more inclusion body proteins
The plasmids containing the genes of five proteins were
transferred into the BL21 (DE3) strain. The cells were
grown in LB medium at 37°C. All over-expressions were
induced by 1 mM IPTG at 37°C for 4 hours. The cells
were harvested at 5,000 g at 4°C for 15 minutes, lysed
with 30 ml of PBS buffer by sonication on ice, and cen-
trifuged (12,000 g, 4°C, 20 minutes). The pellets were
cleaned three times with 30 ml of washing buffer and
centrifuged (12,000 g, 4°C, 15 minutes). The purified five
inclusion body proteins were suspended in PBS buffer
containing 2 M urea at pH 8. Before freeze-thawing, 5ul
of suspension (T) was retained for analysis by SDS-
PAGE, then, the suspension was frozen at −20°C for
overnight and thawed at room temperature, centrifuged
at 12,000 g for 15 minutes at 4°C to collect the super-
natant. The supernatants (5ul) were also analyzed by
SDS–PAGE to estimate the percent solubilization of in-
clusion bodies.
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